Ignite Creation Date:
2024-07-17 @ 10:46 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06483906
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-06-26
Brief Title:
Venetoclax and Azacitidine Combined With Homoharringtonine Followed by Allo-HSCT for Intermediate and High-risk AML
Sponsor:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Organization:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Organization Data
Organization:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Class:
OTHER
Study ID:
SHSYXY-202403-VAH
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Lead Sponsor Class:
OTHER
Responsible Party:
Xianmin Song MD
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Old Name:
None
Old Organization:
None